BackBristol-Myers Squibb Overview

Bristol-Myers Squibb EBIT

EBIT (Earnings Before Interest and Taxes) analysis for BMY.

Quarterly EBIT

$3.27B
↓ 5.57% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$7.75B
↓ 39.52% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin